Clinical Trial Update: Bortezomib and Dexamethasone as Treatment and Maintenance for Multiple Myeloma Relapse [Phase 2]

View source ↗

Summary

This update confirms the completion of a Phase 2 study evaluating bortezomib plus dexamethasone for relapsed multiple myeloma, with a maintenance component.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Velcade (bortezomib)

Snippet

Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED